Ethan Conrad

Mr. Ethan Conrad

University of Washington, Seattle, Washington, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
FWFelicia Najera Watson
Felicia Najera Watson
CDCaroline J. Duncombe
Caroline J. Duncombe
AKAnya C. Kalata
Anya C. Kalata
ECEthan Conrad
Ethan Conrad
SCSumana Chakravarty
Sumana Chakravarty
SMSean C Murphy
Sean C Murphy
7DW8-5 is a potent glycolipid adjuvant that improves malaria vaccine efficacy in mice by inducing IFN-γ and increasing protective CD8+ T cell responses. The addition of 7DW8-5 was previously shown to improve the efficacy of a CD8+ T cell-mediated heterologous ‘prime-and-trap’ malaria vaccine against Plasmodium yoelii sporozoite challenge in inbred female mice. Here, we report significant differential sex-specific responses to 7DW8-5 in inbred and outbred mice. Male mice express significantly less IFN-γ and IL-4 compared to females following intravenous 7DW8-5 administration. Additionally, unlike in female mice, 7DW8-5 did not improve the vaccine efficacy against sporozoite challenge in prime-and-trap vaccinated male mice. Our findings highlight the importance of including both female and male sexes in experimental adjuvant studies.